Market Access Cultural intelligence is key in the global pharma landscape When I started my job as the head of intercontinental markets at Bristol Myers Squibb in February, I was prepared for a steep learning curve.
News FDA clears Viridian's Tepezza rival for thyroid eye disease Viridian has fired a shot across Amgen's bows with the FDA approval of Tepezza rival Lumvoa in thyroid eye disease, a $2bn market.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.